About: PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.39 (-3.24%)
PEPG NASDAQ PepGen Ltd
PepGen Ltd share price
PEPG price activity
Last Price
$2.390
Change (24hr)
-0.08 USD (3.24%)
Volume
1.36M
Volume (4w avg)
-
Open
$2.52
Day Range
$2.28 - $2.52
Previous Close
$2.47
Last Trade
09 Nov, 9:29 pm GMT+0
Delayed
09 Nov, 9:29 pm GMT+0
PEPG price performance
Delayed
09 Nov, 9:29 pm GMT+0
PEPG details
PEPG Market Signals